Your browser is no longer supported. Please, upgrade your browser.
Settings
CRME Cardiome Pharma Corp. daily Stock Chart
CRME [NASD]
Cardiome Pharma Corp.
Index- P/E- EPS (ttm)-0.82 Insider Own0.80% Shs Outstand34.55M Perf Week-1.28%
Market Cap133.71M Forward P/E- EPS next Y-0.30 Insider Trans0.00% Shs Float32.95M Perf Month-16.95%
Income-25.70M PEG- EPS next Q-0.17 Inst Own76.60% Short Float0.93% Perf Quarter-7.86%
Sales23.20M P/S5.76 EPS this Y42.20% Inst Trans-0.21% Short Ratio3.02 Perf Half Y29.00%
Book/sh0.89 P/B4.35 EPS next Y62.00% ROA-38.30% Target Price6.68 Perf Year23.25%
Cash/sh0.82 P/C4.71 EPS next 5Y28.00% ROE-78.50% 52W Range2.35 - 4.84 Perf YTD40.22%
Dividend- P/FCF- EPS past 5Y19.40% ROI-30.20% 52W High-20.04% Beta1.04
Dividend %- Quick Ratio4.10 Sales past 5Y75.80% Gross Margin71.70% 52W Low64.68% ATR0.16
Employees120 Current Ratio4.80 Sales Q/Q-1.70% Oper. Margin-89.60% RSI (14)30.72 Volatility4.34% 3.81%
OptionableYes Debt/Eq0.00 EPS Q/Q28.90% Profit Margin- Rel Volume0.23 Prev Close3.89
ShortableYes LT Debt/Eq0.98 EarningsAug 08 AMC Payout- Avg Volume101.81K Price3.87
Recom2.00 SMA20-7.78% SMA50-8.46% SMA20015.17% Volume23,876 Change-0.51%
Jul-17-17Resumed Canaccord Genuity Buy $8
Dec-22-16Initiated Leerink Partners Outperform
Jun-01-16Initiated H.C. Wainwright Buy $9.50
Jan-08-15Initiated Brean Capital Buy $13
Jan-07-14Initiated R. F. Lafferty Buy $9
Mar-20-12Downgrade RBC Capital Mkts Outperform → Sector Perform $6 → $1.50
Apr-27-11Upgrade RBC Capital Mkts Sector Perform → Outperform $8
Dec-08-10Initiated Wedbush Outperform $8.50
Oct-22-10Reiterated RBC Capital Mkts Sector Perform $10 → $9
Jun-23-10Reiterated UBS Buy $8.80 → $10.75
Aug-12-09Reiterated RBC Capital Mkts Sector Perform $11.50 → $9
Mar-19-09Reiterated Leerink Swann Outperform $8 → $6
Dec-01-08Reiterated Oppenheimer Outperform $18 → $15
Nov-17-08Reiterated Leerink Swann Outperform $15 → $8
Aug-12-08Reiterated RBC Capital Mkts Sector Perform $13.50 → $11.50
Aug-12-08Reiterated Lehman Brothers Equal-Weight $10 → $8
Jul-16-08Downgrade RBC Capital Mkts Outperform → Sector Perform $13.50
Mar-20-08Initiated Wachovia Outperform
Mar-11-08Initiated BMO Capital Markets Market Perform
Oct-09-07Initiated Lehman Brothers Equal-weight
Aug-08-17 11:55PM  Cardiome reports 2Q loss Associated Press
04:00PM  Cardiome Reports Second Quarter 2017 Financial Results PR Newswire
10:40AM  Investor Network: Cardiome Pharma Corp. to Host Earnings Call ACCESSWIRE
Aug-01-17 08:00AM  Cardiome To Hold Second Quarter 2017 Financial Results Conference Call On August 8 CNW Group
Jul-17-17 08:00AM  Cardiome Announces Health Canada Approval of AGGRASTAT® High Dose Bolus Regimen PR Newswire
Jul-04-17 09:16AM  Cardiome's Partner SteadyMed Submits NDA for PAH Injection Zacks
Jul-03-17 08:00AM  Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT® for the Treatment of Pulmonary Arterial Hypertension PR Newswire
Jun-23-17 08:00AM  Cardiome Pharma Corp. Announces Voting Results PR Newswire
08:00AM  Cardiome Pharma Corp. Announces Voting Results CNW Group
Jun-21-17 08:00AM  Cardiome Announces Licensing Agreement for XYDALBA (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel PR Newswire
Jun-12-17 07:30AM  Cardiome Announces Commercial Launch of BRINAVESS® (Vernakalant Hydrochloride) in Canada PR Newswire
07:30AM  Cardiome Announces Commercial Launch of BRINAVESS® (Vernakalant Hydrochloride) in Canada CNW Group
May-19-17 10:22AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 Capital Cube
May-18-17 08:20AM  Cardiome Pharma (CRME) Looks Good: Stock Moves 6.1% Higher Zacks +15.15%
May-17-17 09:59AM  Cardiome (CRME) Q1 Loss Wider Than Expected, Sales Miss Zacks +6.14%
May-16-17 08:00AM  Cardiome Reports Changes To Senior Management Team CNW Group
May-15-17 04:18PM  Cardiome reports 1Q loss Associated Press
04:00PM  Cardiome Reports First Quarter 2017 Financial Results CNW Group
02:30PM  Investor Network: Cardiome Pharma Corp. to Host Earnings Call Accesswire
08:00AM  Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds PR Newswire
08:00AM  Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds CNW Group
May-08-17 08:00AM  Cardiome To Hold First Quarter 2017 Financial Results Conference Call On May 15 CNW Group
Apr-27-17 08:00AM  Cardiome to Present at the Bloom Burton & Co. 6th Annual Healthcare Investor Conference PR Newswire
Apr-10-17 08:45AM  Cardiome Pharma (CRME) Jumps: Stock Adds 6.6% in Session Zacks
Apr-06-17 08:00AM  Cardiome's Partner SteadyMed Announces Successful Completion of Trevyent® Clinical Validation Study PR Newswire
Apr-03-17 08:00AM  Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review PR Newswire
Apr-01-17 01:04PM  CARDIOME PHARMA CORP Financials
Mar-31-17 08:00AM  Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors GlobeNewswire
Mar-20-17 09:04AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
Mar-16-17 09:55AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: 2016 By the Numbers : March 16, 2017 Capital Cube
Mar-14-17 03:02PM  Cardiome Receives Notice of Compliance from Health Canada for its BRINAVESS NDS PR Newswire
03:02PM  Cardiome Receives Notice of Compliance from Health Canada for its BRINAVESS NDS CNW Group
Mar-07-17 04:20PM  Cardiome reports 4Q loss Associated Press
04:00PM  Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results PR Newswire
04:00PM  Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results CNW Group
Mar-03-17 08:00AM  Cardiome Announces Commercial Launch of Xydalba (dalbavancin) in France PR Newswire
Feb-27-17 08:00AM  Cardiome To Hold Fourth Quarter And Full Year 2016 Financial Results Conference Call On March 7 PR Newswire
08:00AM  Cardiome To Hold Fourth Quarter And Full Year 2016 Financial Results Conference Call On March 7 CNW Group
Dec-22-16 06:58AM  Coverage initiated on Cardiome Pharma by Leerink Partners
Dec-20-16 08:00AM  Cardiome Announces Commercial Launch of XYDALBA (dalbavancin) in Germany PR Newswire
Dec-13-16 07:04PM  Is CARDIOME PHARMA CORP (CRME) a Good Stock to Buy? at Insider Monkey
Dec-08-16 11:55AM  Cardiome Announces Commercial Launch of Xydalba (dalbavancin) in the UK PR Newswire
Nov-29-16 08:00AM  Cardiome Advances Toward the UK XYDALBA (dalbavancin) Launch PR Newswire
Nov-09-16 11:48AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016
Nov-07-16 08:12AM  Cardiome reports 3Q loss +9.80%
08:00AM  Cardiome Reports Third Quarter 2016 Financial Results PR Newswire
Nov-01-16 08:00AM  Cardiome to Reschedule Release of Third Quarter 2016 Financial Results PR Newswire
Oct-28-16 08:00AM  Cardiome to Hold Third Quarter 2016 Financial Results Conference Call on November 7 PR Newswire
Oct-26-16 09:14AM  New Strong Sell Stocks for October 26th
Oct-14-16 09:15AM  New Strong Sell Stocks for October 14th
08:00AM  Cardiome Announces Initiation of Commercial Operations in Canada, Eh PR Newswire
Aug-16-16 08:00AM  Cardiome Announces Recent Insider Purchases PR Newswire
Aug-11-16 10:44AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-09-16 04:47PM  Cardiome reports 2Q loss
04:00PM  Cardiome Reports Second Quarter 2016 Financial Results PR Newswire
04:00PM  Cardiome Announces XYDALBA Single Dose Infusion Approval by European Medicines Agency PR Newswire
Aug-08-16 08:00AM  Cardiome Announces the Addition of Two Key Members to its Management Team PR Newswire
Aug-03-16 04:30PM  Cardiome to Hold Second Quarter 2016 Financial Results Conference Call on August 9 PR Newswire
Jul-29-16 09:53AM  Cardiome Closes Public Offering of 11,500,000 Common Shares PR Newswire
Jul-27-16 04:04PM  New York Community Bank Drops in on Wednesdays 52-Week Low Club at 24/7 Wall St.
Jul-26-16 04:08PM  Noodles, Cardiome Lead Tuesdays 52-Week Low Club at 24/7 Wall St. -43.21%
08:38AM  Cardiome Announces Pricing of Public Offering of 10,000,000 Common Shares PR Newswire
Jul-25-16 04:01PM  Cardiome Announces Proposed Public Offering of Common Shares PR Newswire
Jul-18-16 08:00AM  Ionis Pharmaceuticals (IONS) in Focus: Stock Soars 11.3%
Jul-14-16 08:00AM  ESMOCARD® and ESMOCARD LYO® receive pricing approval and reimbursement in Italy PR Newswire
Jun-24-16 08:00AM  Cardiome Pharma Corp. Announces Voting Results PR Newswire
Jun-14-16 08:00AM  Cardiome Announces Term Loan Agreement with CRG-Managed Funds PR Newswire
Jun-04-16 11:25AM  2 Small-Cap Speculative Biohealth Stocks Called to Double or Rise Exponentially at 24/7 Wall St.
May-23-16 01:23PM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
08:25AM  Cardiome Pharma (CRME) Jumps: Stock Moves 8.1% Higher
May-13-16 07:11AM  Cardiome reports 1Q loss
07:00AM  Cardiome Reports First Quarter 2016 Financial Results PR Newswire
May-12-16 08:00AM  Cardiome Announces the Launch of ESMOCARD Solution for Injection in France PR Newswire
May-11-16 08:00AM  Cardiome to Hold First Quarter 2016 Financial Results Conference Call on May 13 PR Newswire
08:00AM  Cardiome Announces Publication of Spanish Emergency Department BRINAVESS Study PR Newswire
May-10-16 09:45AM  Drug Stocks Q1 Earnings Slated on May 11: ACRS, EARS & More Zacks
May-05-16 04:15PM  Cardiome and Allergan Announce XYDALBA (Dalbavancin) Licensing Agreement in International Markets PR Newswire
Apr-28-16 08:00AM  Cardiome to Present at the Bloom Burton & Co. 5th Annual Healthcare Investor Conference PR Newswire
Apr-25-16 09:16AM  New Strong Sell Stocks for April 25th Zacks -5.23%
Apr-21-16 06:30PM  A Closer Look Into Veritas Pharma Gurufocus
Apr-14-16 08:51AM  New Strong Sell Stocks for April 14th
Mar-31-16 08:00AM  Cardiome Announces Publication of Independent Study Comparing BRINAVESS to Ibutilide in Patients with Recent-Onset Atrial Fibrillation PR Newswire
Mar-29-16 09:07AM  New Strong Sell Stocks for March 29th +7.00%
Mar-24-16 08:47AM  New Strong Sell Stocks for March 24th
Mar-23-16 02:54PM  Fairholme Cuts Stake in Sears Holdings Corp (SHLD), Ubben Sells Even More Shares of Motorola Solutions Inc. (MSI), Plus Two Other Moves at Insider Monkey
Mar-21-16 01:25PM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q4, 2015 By the Numbers
10:05AM  New Strong Sell Stocks for March 21st
Mar-10-16 07:27AM  Cardiome reports 4Q loss
07:00AM  Cardiome Reports Fourth Quarter and Full Year 2015 Financial Results PR Newswire
Mar-07-16 05:53PM  Cardiome Announces Filing of Prospectus Supplements PR Newswire
Mar-04-16 03:24PM  Cardiome To Hold Fourth Quarter And Full Year 2015 Financial Results Conference Call On March 10 PR Newswire +6.16%
Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of patients suffering from heart diseases. It offers BRINAVESS (vernakalant (IV)) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The company also provides ESMOCARD and ESMOCARD LYO short-acting beta-blockers used to control rapid heart rate; XYDALBA, a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections; and TREVYENT for the treatment of pulmonary arterial hypertension. It has operations in Canada, the United States, Europe, and internationally. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.